QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
Artificial intelligence is increasingly being used to help scientists accelerate drug discovery and search for new treatments. But for AI tools to work effectively, researchers need to know whether ...
Researchers are studying a machine learning-powered warning system for breast cancer. It works by detecting subtle changes in a mammogram that humans can't spot, but could soon become cancer.
Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study The classification of patients with prostate cancer, based ...
Catching cancer early saves lives — but how can doctors find a few rogue cells in a body made up of trillions? In this groundbreaking TED Talk, biochemist Hani Goodarzi explains how his team ...
A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
A new study reveals that gut bacteria and metabolites may hold the key to detecting serious digestive diseases earlier and more easily. Using AI, scientists found that biomarkers linked to one ...
With March being colon cancer awareness month, it’s a good time to look at some startling numbers on the disease here in the United States. Once considered only a medical concern for middle-age or ...
Researchers combine photonics and nanotechnology to identify molecular cancer signals five to eight years earlier than traditional diagnostic tools. (Nanowerk News) Seemesh Bhaskar believes cancer ...
Across the U.S., hundreds of sites on land or in lakes and rivers are heavily contaminated with hazardous waste produced by human activity. Many of these places, designated as Superfund sites by the ...
Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...
Many eligible patients miss lung cancer screening due to low awareness and systemic barriers, putting underserved groups at higher risk for late-stage disease. She also explained the differences in ...